Endothelial Nitric Oxide Synthase Gene Polymorphisms (G894T, 4b/a and T-786C) and Preeclampsia: Meta-Analysis of 18 Case-Control Studies

DNA and Cell Biology

Volumn 31, Issue 6, 2012, Pages 1136-1145

  Chen, Haiying ^a   Zhao, Ge ^a   Sun, Manni ^a   Wang, He ^a   Liu, Jing ^a   Gao, Wenyan ^a   Meng, Tao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ALLELE; ARTICLE; CASE CONTROL STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; EMBASE; ETHNICITY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INTRON; MEDLINE; META ANALYSIS; PREECLAMPSIA; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; PRE-ECLAMPSIA; PREGNANCY;

EID: 84864039444     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1406     Document Type: Article

References (88)

1. Aggarwal, P.K., Jain, V., and Jha, V. (2010). Endothelial nitric oxide synthase, angiotensin-converting enzyme and angiotensinogen gene polymorphisms in hypertensive disorders of pregnancy. Hypertens Res 33, 473-477.
2. Arngrimsson, R., Hayward, C., Nadaud, S., Baldursdottir, A., Walker, J.J., Liston, W.A., Bjarnadottir, R.I., Brock, D.J., Geirsson, R.T., Connor, J.M., and Soubrier, F. (1997). Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region. Am J Hum Genet 61, 354-362.
3. Barbosa, F., Jr., Sandrim, V.C., Uzuelli, J.A., Gerlach, R.F., and Tanus-Santos, J.E. (2006). eNOS genotype-dependent correlation between whole blood lead and plasma nitric oxide products concentrations. Nitric Oxide 14, 58-64.
4. Barut, F., Barut, A., Dogan Gun, B., Kandemir, N.O., Aktunc, E., Harma, M., Harma, M.I., and Ozdamar, S.O. (2010). Expression of heat shock protein 70 and endothelial nitric oxide synthase in placental tissue of preeclamptic and intrauterine growth-restricted pregnancies. Pathol Res Pract 206, 651-656.
5. Bashford, M.T., Hefler, L.A., Vertrees, T.W., Roa, B.B., and Gregg, A.R. (2001). Angiotensinogen and endothelial nitric oxide synthase gene polymorphisms among Hispanic patients with preeclampsia. Am J Obstet Gynecol 184, 1345-1350; discussion 1350-1341.
6. Begg, C.B., and Mazumdar, M. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088-1101.
7. Benedetto, C., Marozio, L., Ciccone, G., Chieppa, G., Quaglia, M., Matullo, G., Bertola, L., Guarrera, S., Carturan, S., and Stratta, P. (2007). Synergistic effect of renin-angiotensin system and nitric oxide synthase genes polymorphisms in preeclampsia. Acta Obstet Gynecol Scand 86, 678-682.
8. Bernardi, F., Constantino, L., Machado, R., Petronilho, F., and Dal-Pizzol, F. (2008). Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women. J Obstet Gynaecol Res 34, 957-963.
9. Best, L.G., Nadeau, M., Bercier, S., Dauphinais, S., Davis, J., Davis, K., Poitra, S., and Anderson, C.M. (2010). Genetic variants, endothelial function, and risk of preeclampsia among American Indians. Hypertens Pregnancy [Epub ahead of print]. doi: 10.3109/10641955.2010.525-276.
10. Chambers, J.C., Fusi, L., Malik, I.S., Haskard, D.O., De Swiet, M., and Kooner, J.S. (2001). Association of maternal endothelial dysfunction with preeclampsia. JAMA 285, 1607-1612.
11. Chen, L.K., Huang, C.H., Yeh, H.M., Lee, C.N., Shyu, M.K., Hsieh, F.J., Lai, L.P., and Sun, W.Z. (2007). Polymorphisms in the endothelial nitric oxide synthase gene may be protective against preeclampsia in a Chinese population. Reprod Sci 14, 175-181.
12. Corthorn, J., Germain, A.A., Chacon, C., Rey, S., Soto, G.X., Figueroa, C.D., Muller-Esterl, W., Duarte, I., and Valdes, G. (2006). Expression of kallikrein, bradykinin b2 receptor, and endothelial nitric oxide synthase in placenta in normal gestation, preeclampsia, and placenta accreta. Endocrine 29, 491-499.
13. Crawford, D.C., and Nickerson, D.A. (2005). Definition and clinical importance of haplotypes. Annu Rev Med 56, 303-320.
14. DerSimonian, R., and Laird, N. (1986). Meta-analysis in clinical trials. Control Clin Trials 7, 177-188.
15. Donker, R.B., Molema, G., Faas, M.M., Kallenberg, C.G., van Pampus, M.G., Timmer, A., and Aarnoudse, J.G. (2005). Absence of in vivo generalized pro-inflammatory endothelial activation in severe, early-onset preeclampsia. J Soc Gynecol Investig 12, 518-528.
16. Duckitt, K., and Harrington, D. (2005). Risk factors for preeclampsia at antenatal booking: systematic review of controlled studies. BMJ 330, 565.
17. Egger, M., Davey Smith, G., Schneider, M., and Minder, C. (1997a). Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634.
18. Egger, M., Zellweger-Zahner, T., Schneider, M., Junker, C., Lengeler, C., and Antes, G. (1997b). Language bias in randomised controlled trials published in English and German. Lancet 350, 326-329.
19. Fairchild, T.A., Fulton, D., Fontana, J.T., Gratton, J.P., McCabe, T.J., and Sessa, W.C. (2001). Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)- > Asp variant of human endothelial nitric-oxide synthase. J Biol Chem 276, 26674-26679.
20. Fatini, C., Sticchi, E., Gensini, F., Genuardi, M., Tondi, F., Gensini, G.F., Riviello, C., Parretti, E., Mello, G., and Abbate, R. (2006). Endothelial nitric oxide synthase gene influences the risk of pre-eclampsia, the recurrence of negative pregnancy events, and the maternal-fetal flow. J Hypertens 24, 1823-1829.
21. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., Liu-Cordero, S.N., Rotimi, C., Adeyemo, A., Cooper, R., Ward, R., Lander, E.S., Daly, M.J., and Altshuler, D. (2002). The structure of haplotype blocks in the human genome. Science 296, 2225-2229.
22. Grandone, E., Colaizzo, D., Martinelli, P., Pavone, G., Errico, M., Vecchione, G., and Margaglione, M. (2003). Does endothelial nitric oxide synthase gene variation play a role in the occurrence of hypertension in pregnancy? Hypertens Pregnancy 22, 149-155.
23. Hakli, T., Romppanen, E.L., Hiltunen, M., Helisalmi, S., Punnonen, K., and Heinonen, S. (2003). Endothelial nitric oxide synthase polymorphism in preeclampsia. J Soc Gynecol Investig 10, 154-157.
24. Halligan, A., OBrien, E., OMalley, K., Mee, F., Atkins, N., Conroy, R., Walshe, J.J., and Darling, M. (1993). Twenty-fourhour ambulatory blood pressure measurement in a primigravid population. J Hypertens 11, 869-873.
25. Hillermann, R., Carelse, K., and Gebhardt, G.S. (2005). The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia. J Hum Genet 50, 415-419.
26. Hingorani, A.D. (2003). Endothelial nitric oxide synthase polymorphisms and hypertension. Curr Hypertens Rep 5, 19-25.
27. Hocher, B., Chen, Y.P., Hugle, S., Repey, J., Krause, K., Slowinski, T., Godes, M., Schaeffeler, E., Guthmann, F., Wauer, R., Halle, H., Gossing, G., and Pfab, T. (2008). Impact of maternal endothelial nitric oxide synthase gene polymorphisms on blood pressure, protein excretion and fetal outcome in pregnancy. J Hum Hypertens 22, 641-647.
28. Ignarro, L.J. (1989). Biological actions and properties of endothelium- derived nitric oxide formed and released from artery and vein. Circ Res 65, 1-21.
29. Kelm, M., Preik-Steinhoff, H., Preik, M., and Strauer, B.E. (1999). Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway. Cardiovasc Res 41, 765-772.
30. Khan, K.S., Wojdyla, D., Say, L., Gulmezoglu, A.M., and Van Look, P.F. (2006). WHO analysis of causes of maternal death: a systematic review. Lancet 367, 1066-1074.
31. Kim, Y.J., Park, B.H., Park, H., Jung, S.C., Pang, M.G., Ryu, H.M., Lee, K.S., Eom, S.M., and Park, H.Y. (2008). No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations. Twin Res Hum Genet 11, 77-83.
32. Kleinbongard, P., Dejam, A., Lauer, T., Rassaf, T., Schindler, A., Picker, O., Scheeren, T., Godecke, A., Schrader, J., Schulz, R., Heusch, G., Schaub, G.A., Bryan, N.S., Feelisch, M., and Kelm, M. (2003). Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol Med 35, 790-796.
33. Knowles, R.G., and Moncada, S. (1994). Nitric oxide synthases in mammals. Biochem J 298 (Pt 2), 249-258.
34. Kobashi, G., Yamada, H., Ohta, K., Kato, E., Ebina, Y., and Fujimoto, S. (2001). Endothelial nitric oxide synthase gene (NOS3) variant and hypertension in pregnancy. Am J Med Genet 103, 241-244.
35. Kojda, G., and Harrison, D. (1999). Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43, 562-571.
36. Kukor, Z., and Valent, S. (2010). Nitric oxide and preeclampsia. Orv Hetil 151, 2125-2135.
37. Lacchini, R., Silva, P.S., and Tanus-Santos, J.E. (2010). A pharmacogenetics- based approach to reduce cardiovascular mortality with the prophylactic use of statins. Basic Clin Pharmacol Toxicol 106, 357-361.
38. Landau, R., Xie, H.G., Dishy, V., Wood, A.J., Stein, C.M., and Smiley, R.M. (2004). No association of the Asp298 variant of the endothelial nitric oxide synthase gene with preeclampsia. Am J Hypertens 17, 391-394.
39. Lopez-Jaramillo, P., Narvaez, M., Calle, A., Rivera, J., Jacome, P., Ruano, C., and Nava, E. (1996). Cyclic guanosine 3¢,5¢ monophosphate concentrations in pre-eclampsia: effects of hydralazine. Br J Obstet Gynaecol 103, 33-38.
40. Luizon, M.R., Izidoro-Toledo, T.C., Simoes, A.L., and Tanus- Santos, J.E. (2009). Endothelial nitric oxide synthase polymorphisms and haplotypes in Amerindians. DNA Cell Biol 28, 329-334.
41. Lundberg, J.O., Weitzberg, E., and Gladwin, M.T. (2008). The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7, 156-167.
42. Mantel, N., and Haenszel, W. (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22, 719-748.
43. Marroni, A.S., Metzger, I.F., Souza-Costa, D.C., Nagassaki, S., Sandrim, V.C., Correa, R.X., Rios-Santos, F., and Tanus- Santos, J.E. (2005). Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 12, 177-182.
44. Matsubara, S., Takizawa, T., Takayama, T., Izumi, A., Watanabe, T., and Sato, I. (2001). Immuno-electron microscopic localization of endothelial nitric oxide synthase in human placental terminal villous trophoblasts-normal and pre-eclamptic pregnancy. Placenta 22, 782-786.
45. Metzger, I.F., Sertorio, J.T., and Tanus-Santos, J.E. (2007). Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med 43, 987-992.
46. Metzger, I.F., Souza-Costa, D.C., Marroni, A.S., Nagassaki, S., Desta, Z., Flockhart, D.A., and Tanus-Santos, J.E. (2005). Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenet Genomics 15, 565-570.
47. Miyamoto, Y., Saito, Y., Nakayama, M., Shimasaki, Y., Yoshimura, T., Yoshimura, M., Harada, M., Kajiyama, N., Kishimoto, I., Kuwahara, K., Hino, J., Ogawa, E., Hamanaka, I., Kamitani, S., Takahashi, N., Kawakami, R., Kangawa, K., Yasue, H., and Nakao, K. (2000). Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a - 786T- >C mutation associated with coronary spastic angina. Hum Mol Genet 9, 2629-2637.
48. Moncada, S., and Higgs, A. (1993). The L-arginine-nitric oxide pathway. N Engl J Med 329, 2002-2012.
49. Moreno, H., Jr. (2008). Analysis of genetic polymorphisms in preeclampsia: relevance of haplotypes. Eur J Obstet Gynecol Reprod Biol 136, 260; author reply 260-261.
50. Nagassaki, S., Metzger, I.F., Souza-Costa, D.C., Marroni, A.S., Uzuelli, J.A., and Tanus-Santos, J.E. (2005). eNOS genotype is without effect on circulating nitrite/nitrate level in healthy male population. Thromb Res 115, 375-379.
51. Nakayama, M., Yasue, H., Yoshimura, M., Shimasaki, Y., Kugiyama, K., Ogawa, H., Motoyama, T., Saito, Y., Ogawa, Y., Miyamoto, Y., and Nakao, K. (1999). T-786- > C mutation in the 5¢-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99, 2864-2870.
52. Nishizawa, H., Pryor-Koishi, K., Suzuki, M., Kato, T., Sekiya, T., Tada, S., Kurahashi, H., and Udagawa, Y. (2009). Analysis of nitric oxide metabolism as a placental or maternal factor underlying the etiology of pre-eclampsia. Gynecol Obstet Invest 68, 239-247.
53. Pappa, K.I., Roubelakis, M., Vlachos, G., Marinopoulos, S., Zissou, A., Anagnou, N.P., and Antsaklis, A. (2011). Variable effects of maternal and paternal-fetal contribution to the risk for preeclampsia combining GSTP1, eNOS, and LPL gene polymorphisms. J Matern Fetal Neonatal Med 24, 628-635.
54. Persu, A., Stoenoiu, M.S., Messiaen, T., Davila, S., Robino, C., El- Khattabi, O., Mourad, M., Horie, S., Feron, O., Balligand, J.L., Wattiez, R., Pirson, Y., Chauveau, D., Lens, X.M., and Devuyst, O. (2002). Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 11, 229-241.
55. Ray, J.G., Vermeulen, M.J., Schull, M.J., and Redelmeier, D.A. (2005). Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366, 1797-1803.
56. Rhodes, P., Leone, A.M., Francis, P.L., Struthers, A.D., Moncada, S., and Rhodes, P.M. (1995). The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans. Biochem Biophys Res Commun 209, 590-596.
57. Robson, S.C., Hunter, S., Boys, R.J., and Dunlop, W. (1989). Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 256, H1060-H1065.
58. Salimi, S., Naghavi, A., Mokhtari, M., Noora, M., and Yaghmaei, M. (2011). Lack of relationship between endothelial nitric oxide synthase gene 4b/a and T-786C polymorphisms with preeclampsia in southeast of Iran. Arch Gynecol Obstet [Epub ahead of print]. doi: 10.1007/S00404-011-1952-4.
59. Sandrim, V.C., de Syllos, R.W., Lisboa, H.R., Tres, G.S., and Tanus-Santos, J.E. (2007). Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 16, 348-355.
60. Sandrim, V.C., Palei, A.C., Cavalli, R.C., Araujo, F.M., Ramos, E.S., Duarte, G., and Tanus-Santos, J.E. (2008). eNOS haplotypes associated with gestational hypertension or preeclampsia. Pharmacogenomics 9, 1467-1473.
61. Sandrim, V.C., Palei, A.C., Luizon, M.R., Izidoro-Toledo, T.C., Cavalli, R.C., and Tanus-Santos, J.E. (2010a). eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension. Pharmacogenomics J 10, 40-45.
62. Sandrim, V.C., Palei, A.C., Sertorio, J.T., Cavalli, R.C., Duarte, G., and Tanus-Santos, J.E. (2010b). Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Mol Hum Reprod 16, 506-510.
63. Savvidou, M.D., Hingorani, A.D., Tsikas, D., Frolich, J.C., Vallance, P., and Nicolaides, K.H. (2003). Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop preeclampsia. Lancet 361, 1511-1517.
64. Savvidou, M.D., Vallance, P.J., Nicolaides, K.H., and Hingorani, A.D. (2001). Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy. Hypertension 38, 1289-1293.
65. Seremak-Mrozikiewicz, A., Drews, K., and Mrozikiewicz, P.M. (2008). The - 786T/C polymorphism of the endothelial nitric oxide synthase gene in preeclampsia. Eur J Obstet Gynecol Reprod Biol 138, 118-119.
66. Seremak-Mrozikiewicz, A., Drews, K., Barlik, M., Sieroszewski, P., Grzeskowiak, E., and Mrozikiewicz, P. (2011). The significance of - 786T > C polymorphism of endothelial NO synthase (eNOS) gene in severe preeclampsia. J Matern Fetal Neonatal Med 24, 432-436.
67. Serrano, N.C., Casas, J.P., Diaz, L.A., Paez, C., Mesa, C.M., Cifuentes, R., Monterrosa, A., Bautista, A., Hawe, E., Hingorani, A.D., Vallance, P., and Lopez-Jaramillo, P. (2004). Endothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control study. Hypertension 44, 702-707.
68. Sharma, D., Trivedi, S.S., and Bhattacharjee, J. (2011). Oxidative stress and eNOS (Glu298Asp) gene polymorphism in preeclampsia in Indian population. Mol Cell Biochem 353, 189-193.
69. Sibai, B., Dekker, G., and Kupferminc, M. (2005). Pre-eclampsia. Lancet 365, 785-799.
70. Singh, A., Sharma, D., Raghunandan, C., and Bhattacharjee, J. (2010). Role of inflammatory cytokines and eNOS gene polymorphism in pathophysiology of pre-eclampsia. Am J Reprod Immunol 63, 244-251.
71. Tanus-Santos, J.E., Desai, M., and Flockhart, D.A. (2001). Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11, 719-725.
72. Tempfer, C.B., Dorman, K., Deter, R.L., OBrien, W.E., and Gregg, A.R. (2001). An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia. Hypertens Pregnancy 20, 107-118.
73. Tempfer, C.B., Jirecek, S., Riener, E.K., Zeisler, H., Denschlag, D., Hefler, L., and Husslein, P.W. (2004). Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study. J Soc Gynecol Investig 11, 227-231.
74. Tesauro, M., Thompson, W.C., Rogliani, P., Qi, L., Chaudhary, P.P., and Moss, J. (2000). Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A 97, 2832-2835.
75. Tong, X., Li, S., and Zhao, Y. (1998). Expression of endothelial nitric oxide synthase gene in placental villus of preeclampsia. Zhonghua Fu Chan Ke Za Zhi 33, 527-528.
76. Tsukada, T., Yokoyama, K., Arai, T., Takemoto, F., Hara, S., Yamada, A., Kawaguchi, Y., Hosoya, T., and Igari, J. (1998). Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 245, 190-193.
77. Turan, F., Ilhan, N., Kaman, D., Ates, K., and Kafkasli, A. (2010). Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and plasma concentrations of asymmetric dimethylarginine in Turkish pre-eclamptic women without fetal growth retardation. J Obstet Gynaecol Res 36, 495-501.
78. Vallance, P., Collier, J., and Moncada, S. (1989). Effects of endothelium- derived nitric oxide on peripheral arteriolar tone in man. Lancet 2, 997-1000.
79. Villar, J., Abalos, E., Nardin, J.M., Merialdi, M., and Carroli, G. (2004). Strategies to prevent and treat preeclampsia: evidence from randomized controlled trials. Semin Nephrol 24, 607-615.
80. Weir B.S. (1996) Genetic Data Analysis II: Methods for Discrete Population Genetic Data. Sunderland, MA: Sinauer Associates, 91-132.
81. Weiner, C.P., Knowles, R.G., and Moncada, S. (1994). Induction of nitric oxide synthases early in pregnancy. Am J Obstet Gynecol 171, 838-843.
82. Williams, D.J., Vallance, P.J., Neild, G.H., Spencer, J.A., and Imms, F.J. (1997). Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 272, H748-H752.
83. [WHO] World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. (1988). Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 158, 80-83.
84. Yoshimura, T., Chowdhury, F.A., Yoshimura, M., and Okamura, H. (2003). Genetic and environmental contributions to severe preeclampsia: lack of association with the endothelial nitric oxide synthase Glu298Asp variant in a developing country. Gynecol Obstet Invest 56, 10-13.
85. Yoshimura, T., Yoshimura, M., Tabata, A., Shimasaki, Y., Nakayama, M., Miyamoto, Y., Saito, Y., Nakao, K., Yasue, H., and Okamura, H. (2000). Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. J Soc Gynecol Investig 7, 238-241.
86. Yu, C.K., Papageorghiou, A.T., Parra, M., Palma Dias, R., and Nicolaides, K.H. (2003). Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks gestation. Ultrasound Obstet Gynecol 22, 233-239.
87. Zhou, R., Li, W., and Cao, Z. (1998). The changes and significance of the intensity of transcription of endothelial nitric oxide synthase-mRNA in placental tissue from cases of pregnancy induced hypertension. Zhonghua Fu Chan Ke Za Zhi 33, 709-710.
88. Zhou, R., Yang, Y., Xiong, Q., and Cao, X. (2003). Detection of endothelial nitric oxide synthase gene polymorphism in preeclampsia. Sichuan Da Xue Xue Bao Yi Xue Ban 34, 671-673.